The North America Needle-free Injection Systems Market would witness market growth of 16% CAGR during the forecast period (2017 – 2023). Needle free injection technology (NFIT) includes a wide range of drug delivery systems which are used to drive drugs through the skin using any of the forces such as Lorentz, Shock waves, pressure by gas or electrophoresis. The process propels the drug to pass through the skin, and virtually nullifies the use of hypodermic needles.
North America is the region with tremendous market opportunities. The demand for self-administration and rising prevalence of chronic diseases and conditions such as heart disease, stroke, cancer, type 2 diabetes, obesity, and arthritis are the factors driving market growth in North America.
Based on Product, the market is segmented into Fillable Needle-Free Injectors and Prefilled Needle-Free Injectors. Based on Source of Power, the market is segmented into Spring-Based Needle-Free Injectors and Gas Propelled/ Air Forced Injector Systems. Based on Type, the market is segmented into Liquid-Based Needle Free Injectors, Projectile/Depot-Based Needle-Free Injectors, and Powder-Based Needle Free Injectors. Based on Site of Delivery, the market is segmented into Subcutaneous Injectors, Intramuscular Injectors, and Intradermal Injectors. Based on Usability, the market is segmented into Disposable Needle-Free Injectors and Reusable Needle-Free Injectors. Based on Application, the market is segmented into Vaccine Delivery, Insulin Delivery, Pain Management, and Other Application. The report also covers geographical segmentation of Needle-free Injection Systems market. The geographies included in the report are US, Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the North America Needle-free Injection Systems Market. Key companies profiled in the report include Endo International PLC, Antares Pharma, Inc, Pharmajet, Medical International Technology, Inc. (MIT), Injex Pharma AG, National Medical Products, Inc., Valeritas, Inc., European Pharma Group BV, Wright Medical Group, Inc., and Bioject Medical Technologies Inc.
Our reports have been used by over 10K customers, including:
Transformational Health team provides critical insights into the Asian specialty generics market with this research service, highlighting growth opportunities, selected countries’ biopharmaceutical environment, and significant R&D, regulatory, and infrastructure reforms influencing its growth. The report examines similarities and contrasts...
307 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Intranasal Drug Delivery Market to Reach $59.2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Intranasal Drug Delivery estimated at US$44.7 Billion in the year 2020, is projected to reach a revised size of US$59.2 Billion by 2027, growing at a CAGR of 4.1% over the analysis period...
145 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Nanotechnology in Drug Delivery Market to Reach $164.1 Billion by 2027
- Amid the COVID-19 crisis, the global market for Nanotechnology in Drug Delivery estimated at US$47.5 Billion in the year 2020, is projected to reach a revised size of US$164.1 Billion by 2027, growing at aCAGR of 19.4% over...
112 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Novel Drug Delivery Systems (NDDS) Market to Reach $27.2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Novel Drug Delivery Systems (NDDS) estimated at US$7.7 Billion in the year 2020, is projected to reach a revised size of US$27.2 Billion by 2027, growing at aCAGR of 19.7% over...
170 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Connected Drug Delivery Devices Market to Reach $1.5 Billion by 2027
- Amid the COVID-19 crisis, the global market for Connected Drug Delivery Devices estimated at US$166.9 Million in the year 2020, is projected to reach a revised size of US$1.5 Billion by 2027, growing at aCAGR of 36.4% over the...
294 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Controlled Release Drug Delivery Market to Reach $57.3 Billion by 2027
- Amid the COVID-19 crisis, the global market for Controlled Release Drug Delivery estimated at US$36.7 Billion in the year 2020, is projected to reach a revised size of US$57.3 Billion by 2027, growing at a CAGR of 6.6% over...
286 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Electronic Drug Delivery Systems Market to Reach $13.8 Billion by 2027
- Amid the COVID-19 crisis, the global market for Electronic Drug Delivery Systems estimated at US$8.2 Billion in the year 2020, is projected to reach a revised size of US$13.8 Billion by 2027, growing at a CAGR of 7.6% over...
The major factors for the growth of the novel drug delivery systems (NDDS) market include the growing need of controlled release of drugs, advancement in pharmacology promoting increased adoption of novel drug delivery systems (NDDS), and technological advancements promoting the development of NDDS. There has been a remarkable increase...
Report Scope: The scope of the report includes an overview of the global market for nanoparticles in biotechnology, drug development and drug delivery, and analyses of global market trends, using 2019 as the base year and forecasting 2020 through 2025 with compound annual growth rate (CAGR) projections. The report...
Nanoparticle
Drug Delivery
Drug Development
World
Europe
United States
APAC
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.